Novamont targets for 40% to 100% bio-based of Mater-Bi bioplastic

Popular Plastics amp; Packaging group

首页> 外文期刊>Popular Plastics & Packaging >Novamont targets for 40% to 100% bio-based of Mater-Bi bioplastic

【24h】

Novamont targets for 40% to 100% bio-based of Mater-Bi bioplastic

机译：Novamont靶向40％至100％基于Bio Bi Bioplastic的目标

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

AT THE G7 environmental summit in Bologna recently, Novamont announced its unilateral decision to introduce a 40% minimum threshold for bio-based content in all of its Mater-Bi bioplastics.

机译：在博洛尼亚的G7环境峰会最近，诺曼组织宣布其单方面决定在其所有Mater-BI生物塑料塑料中引入40％的基于生物含量的阈值。

著录项

来源
《Popular Plastics & Packaging》 |2017年第8期|共1页
作者
Popular Plastics amp; Packaging group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类合成树脂与塑料工业;
关键词

相似文献

外文文献
中文文献
专利

1. Novamont targets for 40% to 100% bio-based of Mater-Bi bioplastic [J] . Popular Plastics amp, Packaging group Popular Plastics & Packaging . 2017,第8期

机译：Novamont靶向40％至100％基于Bio Bi Bioplastic的目标
2. Novamont Boosts Production Capacity Of Mater-Bi Compostable Bioplastics [J] . PetroChemical News group PetroChemical News . 2019,第40期

机译：Novamont提高了Mater-Bi Compostable Bioplastics的生产能力
3. Novamont Bioplastics and bio-based products at K 2019 [J] . Popular Plastics amp, Packaging Group Popular Plastics & Packaging . 2019,第11期

机译：Novamont Bioplastics和K 2019的生物产品
4. CAN MISCANTHUS X GIGANTEUS FIBRES BE UTILISED AS FILLER/REINFORCEMENT IN NOVAMONT MATER-BI? [C] . R. Mark Johnson, Stuart Barnes, Nick Tucker 23rd Riso International Symposium on Materials Science, Sep 2-5, 2002, Roskilde, Denmark . 2002

机译：可以将MISCANTHUS X GIGANTEUS纤维用作NOVAMONT MATER-BI中的填充物/增强材料吗？
5. LCA comparison of 100 % bio-based PET synthesized from different PTA pathways. [D] . Akanuma, Yasuhiko. 2013

机译：从不同PTA途径合成的100％生物基PET的LCA比较。
6. Effects of Quality Control Targets (SpO2≠100 PaCO2/40 mmHg Pmean/10 cmH2O) on Outcomes in Patients in the ICU [O] . Pan Pan, Longxiang Su, Qing Zhang, 2020

机译：质量控制目标（SpO2≠100％PaCO2 / 40 mmHgPmean / 10 cmH2O）对ICU患者结局的影响
7. Anti-drug antibodies to LMB-100 are enhanced by mAbs targeting OX40 and CTLA4 but not by mAbs targeting PD1 or PDL-1 [O] . Ronit Mazor, Emily King, Ira Pastan 2018

机译：通过靶向OX40和CTLA4的MAb增强对LMB-100的抗药物抗体，但不是靶向PD1或PDL-1的MAb

Novamont targets for 40% to 100% bio-based of Mater-Bi bioplastic

摘要

著录项

相似文献

相关主题

期刊订阅